首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD3E Recombinant Antibody(Visilizumab)

Anti-Human CD3E Recombinant Antibody(Visilizumab)

产品编号

YR1046

别名

科研级 Visilizumab ( 维西珠单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Visilizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Visilizumab ( 维西珠单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Visilizumab
Catalog NumberYR1046
Molecular NameVisilizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG2
FormulationPBS, pH7.5
BackgroundVisilizumab (tentative trade name Nuvion, PDL BioPharma Inc.) is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease. Visilizumab binds to the CD3 receptor on certain activated T cells without affecting resting T cells. It is currently under clinical studies for the treatment of ulcerative colitis and Crohn's disease.
CAS Number219716-33-3
ApplicationELISA, IHC, IF, IP, FCM, FuncS
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCD3E[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价